Petros Pharmaceuticals, Inc. (PTPI) Net margin 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) net profit margin by fiscal year — reported net income divided by reported revenue.
-280.1%FY2024 · since FY2020: -215.3% → -280.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -280.1% | -139.9 pp |
| FY2023 | -140.2% | +194.2 pp |
| FY2022 | -334.4% | -219.4 pp |
| FY2021 | -115.0% | +100.3 pp |
| FY2020 | -215.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice